Ginkgo Bioworks (DNA) Misses Q3 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. SBUX
3. LEVI
4. NVDA
5. CMG
6. HUM
7. STZ
8. AAPL
9. SPY
10. GOOGL

Go back to Ginkgo Bioworks (DNA) Misses Q3 EPS by 7c

Ginkgo Bioworks Reports Third Quarter 2023 Financial Results

November 8, 2023 5:01 PM EST

Ginkgo added 21 new Cell Programs to the Foundry platform in Q3 2023

Entered into strategic cloud and AI partnership with Google Cloud; first milestone recently achieved

Signed new multi-target RNA drug discovery collaboration with Pfizer in which Ginkgo is eligible to receive research fees and development and commercial milestone payments of up to $331 million

Ginkgo ended Q3 2023 with over $1.0 billion in cash and cash equivalents, maintaining a multi-year runway as Ginkgo continues... More